These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36779676)

  • 1. Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa.
    Segura Palacios JM; Soto Moreno A; Valladares Millán I; Rivas Ruiz F; Cuenca Barrales C; Molina Leyva A
    J Dermatolog Treat; 2023 Dec; 34(1):2179368. PubMed ID: 36779676
    [No Abstract]   [Full Text] [Related]  

  • 2. Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa.
    Braunberger TL; Nartker NT; Nicholson CL; Nahhas AF; Parks-Miller A; Hanna Z; Jayaprakash R; Ramesh MS; Rambhatla PV; Hamzavi IH
    Int J Dermatol; 2018 Sep; 57(9):1088-1093. PubMed ID: 29774531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ertapenem for the treatment of Hidradenitis suppurativa: how much do we need it?
    Mendes-Bastos P; Martorell A; Magina S
    Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):582-583. PubMed ID: 29803362
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemoglobin as an indicator of disease activity in severe hidradenitis suppurativa.
    Braunberger TL; Lowes MA; Hamzavi IH
    Int J Dermatol; 2019 Sep; 58(9):1090-1091. PubMed ID: 30094834
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.
    Join-Lambert O; Coignard-Biehler H; Jais JP; Delage M; Guet-Revillet H; Poirée S; Duchatelet S; Jullien V; Hovnanian A; Lortholary O; Nassif X; Nassif A
    J Antimicrob Chemother; 2016 Feb; 71(2):513-20. PubMed ID: 26565016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa- Reply.
    Lyons AB; Parks-Miller A; Zubair R; Hamzavi IH
    Int J Dermatol; 2019 Apr; 58(4):E88. PubMed ID: 30515760
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the Editor regarding "Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa".
    Hegde SG; Ravikumar BC
    Int J Dermatol; 2019 Apr; 58(4):E87-E88. PubMed ID: 30246278
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.
    Alikhan A; Sayed C; Alavi A; Alhusayen R; Brassard A; Burkhart C; Crowell K; Eisen DB; Gottlieb AB; Hamzavi I; Hazen PG; Jaleel T; Kimball AB; Kirby J; Lowes MA; Micheletti R; Miller A; Naik HB; Orgill D; Poulin Y
    J Am Acad Dermatol; 2019 Jul; 81(1):91-101. PubMed ID: 30872149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
    Ingram JR; Burton T
    Br J Dermatol; 2017 Feb; 176(2):281-282. PubMed ID: 28244073
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical management of hidradenitis suppurativa.
    Orenstein LA; Micheletti RG
    Semin Cutan Med Surg; 2017 Jun; 36(2):62-66. PubMed ID: 28538746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidradenitis suppurativa and Crohn's disease: two cases that support an association.
    Yazdanyar S; Miller IM; Jemec GB
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: A case series.
    Yen CF; Huang YH; Chi CC
    Indian J Dermatol Venereol Leprol; 2021; 87(2):223-226. PubMed ID: 31389375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
    Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of hidradenitis suppurativa in women.
    Collier EK; Parvataneni RK; Lowes MA; Naik HB; Okun M; Shi VY; Hsiao JL
    Am J Obstet Gynecol; 2021 Jan; 224(1):54-61. PubMed ID: 32980357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of 5-aminolevulinic acid photodynamic therapy in the treatment of hidradenitis suppurativa: a report of 5 cases.
    Andino Navarrete R; Hasson Nisis A; Parra Cares J
    Actas Dermosifiliogr; 2014; 105(6):614-7. PubMed ID: 24472519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment options in severe hidradenitis suppurativa].
    Mooij JE; van't Oost L; Leenarts MF; Mekkes JR
    Ned Tijdschr Geneeskd; 2011; 155():A1912. PubMed ID: 21426594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa.
    Ricceri F; Rosi E; Di Cesare A; Pescitelli L; Fastame MT; Prignano F
    Dermatol Ther; 2020 Nov; 33(6):e14387. PubMed ID: 33030281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hidradenitis suppurativa.
    Drug Ther Bull; 2016 Sep; 54(9):102-5. PubMed ID: 27585997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.